Lumacaftor is a pharmaceutical drug that acts as a chaperone during protein folding and increases the number of CFTR proteins that are trafficked to the cell surface.
This report contains market size and forecasts of Lumacaftor API in global, including the following market information:
Global Lumacaftor API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Lumacaftor API Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Lumacaftor API companies in 2021 (%)
The global Lumacaftor API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Lumacaftor API include VulcanChem, Tecoland, FCDA, Viruj Pharma, Pharmaffiliates, Taizhou Crene Biotechnology, Shanghaizehan biopharma technology, Shijiazhuang Dingmin Pharmaceutical Sciences and AlchemyPharm. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lumacaftor API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lumacaftor API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Lumacaftor API Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Lumacaftor API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Lumacaftor API Market Segment Percentages, by Application, 2021 (%)
Research
Pharmaceutical
Global Lumacaftor API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Lumacaftor API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lumacaftor API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Lumacaftor API revenues share in global market, 2021 (%)
Key companies Lumacaftor API sales in global market, 2017-2022 (Estimated), (MT)
Key companies Lumacaftor API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
VulcanChem
Tecoland
FCDA
Viruj Pharma
Pharmaffiliates
Taizhou Crene Biotechnology
Shanghaizehan biopharma technology
Shijiazhuang Dingmin Pharmaceutical Sciences
AlchemyPharm